Skip to main content

Advertisement

Log in

Efficacy and safety of rituximab in rheumatoid arthritis patients refractory to methotrexate

  • Clinicals Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Moreland LW, Alten R, Van den BoschF, et al.: Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double blind, placebo controlled clinical trial evaluating CTLA-4Iq and LEA294 eighty five days after the first infusion. Arthritis Rheum 2002, 46:1470–1479.

    Article  PubMed  CAS  Google Scholar 

  2. Teng GG, Turkiewicz AM, Moreland LW: Abatacept: A costimulatory inhibitory for treatment of rheumatoid arthritis. Expert Opin Biol Ther 2005, 5:1245–1254.

    Article  PubMed  CAS  Google Scholar 

  3. Bluestone JA, St Clair EW, Turka LA: CTLA4Ig: bridging the basic immunology with clinical application. Immunity 2006, 24:233–238.

    Article  PubMed  CAS  Google Scholar 

  4. Edwards JC, Cambridge G: Prospects for B-cell-targeted therapy in autoimmune disease. Rheumatology 2005, 44:151–156.

    Article  PubMed  CAS  Google Scholar 

  5. Edwards JC, Szczepanski L, Szechinski J, et al.: Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004, 350:2572–2581.

    Article  PubMed  CAS  Google Scholar 

  6. Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC: Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:613–620.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreland, L. Efficacy and safety of rituximab in rheumatoid arthritis patients refractory to methotrexate. Curr Rheumatol Rep 8, 368 (2006). https://doi.org/10.1007/s11926-006-0067-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-006-0067-6

Keywords

Navigation